Presenting companies announced for major investment summit

The Australasian Life Science Investment Summit 2012, the largest investment event of its kind in the Southern Hemisphere will again be held in conjunction with Australia’s premier biotechnology industry conference, AusBiotech 2012. Companies selected to present at the event have been announced.

The event features 40 investment pitching presentations from Australasia’s most promising life science companies, in one place on one day. Registration is free for bona fide investors only and places are limited for the Summit to be held at the Melbourne Convention Centre on Friday 2 November.

The Summit will commence from 9:00am and concludes with a networking reception finishing at 5:30pm. AusBiotech is pleased to announce the presenting companies, which include:

• Acrux
• Agenix Limited
• Allied Healthcare Group
• Benitec Biopharma
• BioDiem
• Bionomics
• Biotron
• Bluechiip Limited
• Broadvector Limited
• CBIO
• Cellmid Limited
• Circadian Technologies
• Clarity Pharmaceuticals
• Consegna Group
• Elastagen
• Genetic Technologies
• Global Kinetics Corporation
• Hatchtech
• Living Cell Technologies
• Minomic International
• Nanosonics
• Neuren Pharmaceuticals
• Nextgen Plants
• Nextvet Biopharma
• Optiscan Imaging
• Osprey Medical
• Phosphagenics
• Phylogica
• Prana Biotechnology
• pSivida
• QRX Pharma
• Spinifex Pharmaceuticals
• Starpharma
• Sunshine Heart
• Tissue Therapies
• Ultraceuticals
• Xenexus Pharmaceuticals

For further details please contact AusBiotech’s Investment Program Manager, Hayley Laing on or +61 3 9828 1400. Information is also available at the ALSIS 2012 event website.